Aricept Complexed with Acetylcholinesterase (Arabic)
From Proteopedia
(Difference between revisions)
| (6 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | <StructureSection load='1eve' size='450' side='right' scene=' | + | <StructureSection load='1eve' size='450' side='right' scene='29/2908/1eve_e20_cartoon/1' caption=''> |
[[Image:E2020_interactins_in_AChE_gorge.jpg|left|250px]]<br /> | [[Image:E2020_interactins_in_AChE_gorge.jpg|left|250px]]<br /> | ||
<p dir='rtl'> | <p dir='rtl'> | ||
| Line 16: | Line 16: | ||
==نتائج== | ==نتائج== | ||
<p dir='rtl'> | <p dir='rtl'> | ||
| - | تظهر الأشعة السينية لهيكلة المركب '''(E2020 – TcAChE)''' أن ال- '''E2020''' له <scene name='1eve/E2020_close_up_with_84_279/13'> | + | تظهر الأشعة السينية لهيكلة المركب '''(E2020 – TcAChE)''' أن ال- '''E2020''' له <scene name='1eve/E2020_close_up_with_84_279/13'>unique orientation</scene> على طول منطقة الموقع النشط في داخل الأستيلكولينستراز ، وبمتد هذا التوافق من موقع فرعي أنيوني <scene name='1eve/E2020_close_up_with_84lbld/7'> (W84) </scene> من الموقع النشط - في الجزء السفلي ، إلى موقع أنيوني خارجي <scene name='1eve/E2020_close_up_with_84_279lbld/5'> (W279) </scene>- في الجزء العلوي ،وذلك من خلال روابط aromatic stacking interactions مع أحماض نكيليوتيدية أروماتية. بالرغم من ذلك لا يتفاعل ال- '''E2020''' بشكل مباشر مع أي من ثالوث الحفاز أو ال-'oxyanion hole' ولكن فقط بشكل <scene name='1eve/E20_interactionshown/8'> indirectly via solvent molecule </scene>.</p> |
==خاتمة== | ==خاتمة== | ||
<p dir='rtl'> | <p dir='rtl'> | ||
| Line 29: | Line 29: | ||
Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs., Kryger G, Silman I, Sussman JL, Structure. 1999 Mar 15;7(3):297-307. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=10368299 10368299] | Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs., Kryger G, Silman I, Sussman JL, Structure. 1999 Mar 15;7(3):297-307. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=10368299 10368299] | ||
| - | [[ | + | [[ar:Aricept_Complexed_with_Acetylcholinesterase (Arabic)]] |
| + | [[ca:Aricept_Complexed_with_Acetylcholinesterase (Catalan)]] | ||
| + | [[zh:Aricept_Complexed_with_Acetylcholinesterase (Chinese)]] | ||
| + | [[cs:Aricept_Complexed_with_Acetylcholinesterase (Czech)]] | ||
| + | [[de:Aricept_Complexed_with_Acetylcholinesterase (German)]] | ||
| + | [[en:Aricept_Complexed_with_Acetylcholinesterase]] | ||
| + | [[es:Aricept_Complexed_with_Acetylcholinesterase (Spanish)]] | ||
| + | [[fr:Aricept_Complexed_with_Acetylcholinesterase (French)]] | ||
| + | [[he:Aricept_Complexed_with_Acetylcholinesterase (Hebrew)]] | ||
| + | [[it:Aricept_Complexed_with_Acetylcholinesterase (Italian)]] | ||
| + | [[ru:Aricept_Complexed_with_Acetylcholinesterase (Russian)]] | ||
| + | [[sk:Aricept_Complexed_with_Acetylcholinesterase (Slovak)]] | ||
| + | [[vi:Aricept_Complexed_with_Acetylcholinesterase (Vietnamese)]] | ||
| + | [[tr:Aricept_Complexed_with_Acetylcholinesterase (Turkish)]] | ||
| - | [[ar:1eve (Arabic)]] | ||
| - | [[zh:1eve (Chinese)]] | ||
| - | [[de:1eve (German)]] | ||
| - | [[en:1eve]] | ||
| - | [[es:1eve (Spanish)]] | ||
| - | [[fr:1eve (French)]] | ||
| - | [[it:1eve (Italian)]] | ||
| - | [[ru:1eve (Russian)]] | ||
| - | [[tr:1eve (Turkish)]] | ||
| - | [[he:1eve (Hebrew)]] | ||
[[Category: Acetylcholinesterase]] | [[Category: Acetylcholinesterase]] | ||
Current revision
| |||||||||||
مراجع
Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs., Kryger G, Silman I, Sussman JL, Structure. 1999 Mar 15;7(3):297-307. PMID:10368299
Page seeded by OCA on Thu Nov 8 12:39:55 2007
Proteopedia Page Contributors and Editors (what is this?)
Muneef Ayyash, Jaime Prilusky, Alexander Berchansky, Judy Voet, Joel L. Sussman, Fred Vellieux, Eran Hodis
